LAF4, an AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia
✍ Scribed by Anne R.M. von Bergh; H. Berna Beverloo; Paul Rombout; Elisabeth R. van Wering; Margreet H. van Weel; Geoffrey C. Beverstock; Philip M. Kluin; Rosalyn M. Slater; Ed Schuuring
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 324 KB
- Volume
- 35
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Infant acute lymphoblastic leukemia (ALL) with MLL gene rearrangements is characterized by a proB phenotype and a poor clinical outcome. We analyzed an infant proB ALL with t(2;11)(p15;p14) and an MLL rearrangement on Southern blot analysis. Rapid amplification of cDNA ends–polymerase chain reaction (PCR) and reverse transcriptase‐PCR identified the LAF4 gene mapped on chromosome region 2q11.2–q12 as a fusion partner of the MLL gene. The LAF4 gene was identified previously by its high sequence homology to the AF4 protein and encodes a protein of 1,227 amino acids. The t(4;11)(q21;q23), creating the MLL‐AF4 chimeric transcripts, is the predominant 11q23 chromosome translocation in infant ALL and is associated with an extremely poor prognosis. Our findings further suggest that fusion of MLL to one of the AF4 family members (AF4/LAF4/AF5Q31) might determine a proB‐cell phenotype in infant leukemia. © 2002 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract We have shown that the __EB1__ (__MAPRE1__) gene, at 20q11.2, is fused to __MLL__ in an adult patient with pro‐B acute lymphoblastic leukemia. Southern blot analysis indicated that a rearrangement of the __MLL__ gene was involved in the chromosomal abnormality. cDNA panhandle polymerase
## Abstract The mixed lineage leukemia, __MLL__, gene is frequently rearranged in patients with secondary leukemia following treatment with DNA topoisomerase II inhibitors. By FISH and Southern blot analyses we identified a rearrangement in the __MLL__ gene due to a novel t(3;11)(q28;q23) chromosom
## Abstract __AML1__ is among the most frequent targets of chromosomal rearrangements in human leukemias. We report here the molecular analysis of a t(4;21)(q28;q22) that has disrupted __AML1__ in a patient with de novo T‐cell acute lymphoblastic leukemia. By using 3′‐RACE analysis, we show that th
## Abstract The __AML1__ gene (also known as __RUNX1__) at 21q22 codes for core binding factor (CBF) α, which forms a heterodimer with CBF β that acts as a transcriptional activating factor. CBF is a critical regulator in the generation and differentiation of definitive hematopoietic stem cells and